Abel Hall LLC’s Wave Life Sciences WVE Stock Holding History

Abel Hall LLC’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-16,569	Closed	-$96.3K	–	1044
2026 Q2	$96.3K	Buy	+16,569	New	+$110K	0.02%	841

Other funds holding WVE

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return

GSK plc London $497M AUM 35.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Abel Hall LLC's WVE Position: Q3 2026 in Review

Abel Hall LLC sold out of Wave Life Sciences (WVE) in Q3 2026, closing a stake of 16,569 shares — an estimated $96.3K sold.

Abel Hall LLC first reported a position in WVE in Q2 2026 and held it in 1 quarter. The position peaked at $96.3K in Q2 2026. 67 funds tracked by Wall St. Rank hold WVE as of Q3 2026.

Abel Hall LLC reported no remaining Wave Life Sciences position as of Q3 2026 after selling out during the quarter.
Abel Hall LLC sold 16,569 Wave Life Sciences shares in Q3 2026, an estimated $96.3K.
Abel Hall LLC first reported a position in Wave Life Sciences in Q2 2026 and held it in 1 quarter.
Abel Hall LLC's Wave Life Sciences position peaked at $96.3K in Q2 2026.
67 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.